Clinical Trial Update: Diagnostic and Therapeutic Potential of Substance P/ NK1R Receptor in Primary Dysmenorrhea [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing the diagnostic and therapeutic potential of Substance P/NK1R receptor signaling in primary dysmenorrhea has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysmenorrhea

Snippet

Sponsor: Lahore Medical Research Center, LLP | Conditions: Primary Dysmenorrhea | Phase 3 | Status: COMPLETED